Search...
Features
Assets
Blog
Help
Learn
Get App
Login
Sign Up
Allogene Therapeutics (ALLO) Q1 2024 Earnings
ALLO
+6.75%
13
May
Confirmed
Q2 2023
Q3 2023
Q4 2023
Q1 2024
-0.59
-0.52
-0.44
-0.37
Details
Expected EPS
-0.41
Actual EPS
-0.38
Surprise EPS
0.03
Surprise Percent
+7.32%
Description
Allogene Therapeutics (ALLO) has reported earnings of -0.38 per share for Q1 2024.
0 Comments
Share your thoughts
Get the Stock Events App
Sign up for a Stock Events account to create your own watchlists and track your portfolio or dividends.
Sign Up
Login